跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ENLAFAX-XR venlafaxine 150mg modified release capsule blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
ENLAFAX-XR venlafaxine 150mg modified release capsule blister pack
Approved
STANDARD
ENLAFAX-XR venlafaxine 150mg modified release capsule blister pack
Alphapharm Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
be4707ea03ddd732
Company
Alphapharm Pty Ltd
Type
Standard
Approval Details
Approval Id
be4707ea03ddd732
Product Name
ENLAFAX-XR venlafaxine 150mg modified release capsule blister pack
Artg Id
143552
Artg Name
ENLAFAX-XR venlafaxine 150mg modified release capsule blister pack
Sponsor
Alphapharm Pty Ltd
Company Detail Path
/organization/alphapharm-pty-ltd
Artg Date
2009-04-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/d5608d16a8cd745ad518c3c7fdb2ae0c.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/ae062a83a28bb7c342595b3bab7ef3fd.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
be4707ea03ddd732
Type
Standard
Back to TGA Approvals